Punctuated equilibrium

From WikiMD's WELLNESSPEDIA

Punctuated equilibrium is a theory in evolutionary biology which proposes that most species will exhibit little net evolutionary change for most of their geological history, remaining in an extended state called stasis. When significant evolutionary change occurs, the theory proposes that it is generally restricted to rare and rapid (on a geologic time scale) events of branching speciation.

Overview[edit]

Punctuated equilibrium is commonly contrasted against phyletic gradualism, the idea that evolution generally occurs uniformly and by the steady and gradual transformation of whole lineages (called anagenesis). In this view, evolution is seen as generally smooth and continuous.

In 1972, Stephen Jay Gould and Niles Eldredge first proposed the theory of punctuated equilibrium. They argued that nearly every evolutionary change occurs during speciation.

Development of the theory[edit]

The concept of punctuated equilibrium originated in the work of Mayr in 1954 and was subsequently taken up by Stephen Jay Gould and Niles Eldredge in 1972. They used the term to describe the evolutionary dynamics of some groups of organisms. They argued that the degree of gradualism championed by Charles Darwin was virtually nonexistent in the fossil record, and that stasis dominates the history of most fossil species.

Criticism and acceptance[edit]

The concept of punctuated equilibrium has been a matter of debate within the scientific community. Some scientists argue that it is a significant departure from the mainstream view of evolution as a slow, gradual process, while others argue that the idea is a minor revision, or simply a recharacterization of the mainstream view. Despite the controversy, punctuated equilibrium has become a widely accepted concept within evolutionary biology.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.